A selective p38 MAP kinase (p38 MAPK) inhibitor, SB202190, induced apoptotic cell death of a macrophage-like cell line, J774.1, in the presence of lipopolysaccharide (LPS), as judged by DNA nicks revealed by terminal deoxy transferase (TdT)-mediated dUTP nick end labeling (TUNEL), activation of caspase-3, and subsequent release of lactate dehydrogenase. This cytotoxicity was dependent on both LPS and SB202190, and such inhibitors of the upstream LPS-signaling cascade as polymyxin B and TPCK blocked this macrophage cell death. SB202190 suppressed the kinase activity of p38, leading to inhibition of activation of MAPKAPK2 and then the subsequent phosphorylation of hsp27 in LPS-treated macrophages both in vitro and in vivo, but an inactive analog of SB202190, SB202474, did not. There was a threshold of the time of addition of SB202190 to LPS-treated macrophages to induce apoptosis, which was before full transmission of p38 activity to a direct downstream kinase, MAPKAPK2. Besides, localization of phosphorylated hsp27 in Golgi area of the LPS-treated macrophages was suppressed by SB202190, while it was not by SB202474. These results suggest that selective inhibition of p38 MAPK activity in LPS-induced MAP kinase cascade leads to apoptosis of macrophages. ß
Introduction
Lipopolysaccharide (LPS) is one of the major components of the outer membrane of Gram-negative bacteria, and it activates macrophages [1, 2] to generate TNF-K, IL-1, and IL-6 [3^6], prostaglandins, or nitric oxide (NO) [7, 8] . This LPS signal transduction cascade has been reported to include activation of MAP kinase family members such as Erk1/Erk2, JNK, and p38 MAPK [9^11] . Production of a selective p38 MAPK inhibitor, SB202190 [9] , has allowed the studies on the role of this kinase in the production of TNF-K, IL-1, and NO by LPS-treated macrophages [9] , the importance of this kinase in LPS signaling processes being shown.
On the other hand, the p38 MAPK pathway has also been reported to play a pivotal role in the induction of apoptosis; various stimuli which induce apoptosis activate p38 MAPK, and this activation is well correlated with DNA ladder formation and nuclear condensation [12, 13] . Moreover, continuous activation of MKK3 or MKK6, which is the kinase directly upstream of p38 MAPK [19, 20] , is also able to induce apoptosis [12, 14] . However, the addition of a p38 MAPK inhibitor such as SB202190 or SB203580 did not always suppress the apoptosis which had been shown to accompany by the activation of p38 MAPK [12^14], suggesting controversial roles of a p38 MAPK in apoptosis.
Recently, we have shown that LPS induces macrophage cell death through apoptosis under the inhibition of protein synthesis [15] , although the mechanisms of induction of apoptosis remain largely unknown. In this study, we show a new type of cytotoxicity mediated through apoptosis induced by LPS and SB202190 in a mouse macrophage-like cell line, J774.1. We also show some evidence to suggest the anti-apoptotic pathway through p38 MAPK in LPS-treated macrophages.
Materials and methods

Cell culture
Culturing of the JA-4 cell line, an LPS-sensitive subline of a murine macrophage-like cell line, J774.1, and that of the LPS1916 cell line, an LPSresistant mutant cell line originating from JA-4 [6] , were performed as described previously [16] . In brief, the cells were maintained and cultured in 10 ml of Ham's F-12 medium (Flow Laboratories, McLean, VA) supplemented with 10% heat-inactivated fetal bovine serum (Gibco, Grand Island, NY), 50 U/ml of penicillin and 50 Wg/ml of streptomycin (Flow Laboratories) in a 100-mm plastic dish (Falcon 1001; Becton Dickinson, Lincoln Park, NJ) at 37³C in a CO 2 incubator (5% CO 2^9 5% humidi¢ed air).
Assaying of cytotoxicity
The cytotoxic e¡ect of SB202190 with LPS was examined using JA-4 cells as described previously [16] . The cells were seeded at 2U10 5 cells/well/0.5 ml of the culture medium described above on £at-bottomed plates with 24-well clusters (Coster 3524; Cambridge, MA), and then incubated overnight at 37³C. The medium was replaced with 0.5 ml of fresh medium supplemented with 100 WM SB202190 (Calbiochem; Cambridge, MA). After incubation at 37³C for 15 min, 100 ng/ml LPS (LPS from Escherichia coli O55:B5; Sigma, St. Louis, MO) was added to the cultures, and the cells were incubated at 37³C for a further 4 h. The culture supernatants were collected and then centrifuged at 10 000 rpm for 1 min at 4³C. Aliquots (300 Wl) of the resultant supernatants were used for the lactate dehydrogenase (LDH) assay. As a negative control, the culture supernatant was collected at zero time incubation and the total LDH activity was determined with the supernatant of the cells, treated with 0.1% Triton X-100. The LDH activity was determined with an assay kit for LDH (Kyokuto, Tokyo), according to the manufacturer's protocol. Cytotoxicity was expressed as % of the total activity according to the following formula:
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TUNEL staining
JA-4 cells were seeded at 4U10 4 cells/100 Wl of medium into the wells on a slide glass (Cel-Line, USA), and then incubated at 37³C overnight. The medium was replaced with 100 Wl of fresh medium supplemented with 100 WM SB202190, and then the cells were incubated for 15 min. Then 100 ng/ml LPS was added to the culture, and the cells were incubated for a further 4 h, and then ¢xed directly with 3% formaldehyde in the culture medium, pH 7.4, for 10 min. After washing the ¢xed cells with PBS(3) repeatedly, staining was performed with an In Situ Cell Death Detection Kit, TMR red (Boehringer Mannheim) or an Apoptosis In Situ Detection Kit (Wako, Osaka, Japan) according to the manufacturer's protocol based on TdT-mediated polymerization of nucleotides to free 3P-OH DNA ends (TUNEL reaction) with TMR red-conjugated nucleotide or biotin-dUTP, respectively. Detection of TUNEL-positive cells was performed either with £uorescence of TMR red-conjugated nucleotides under a confocal microscope (Carl Zeiss) or with diaminobenzidine (DAB) formed by H 2 O 2 and HRP-conjugated anti-biotin antibody, under a phase-contrast microscope (Nikon). Photographs were taken in random ¢elds in either case and more than 150 cells were observed in each sample from the repeated experiments.
Immunohistochemistry
Cells were seeded onto a slide glass, incubated overnight, treated with 100 WM SB202190 or SB202474 in the fresh medium and then with 100 ng/ml LPS, and ¢nally ¢xed with 3% formaldehyde as described above. The cells were rinsed with phosphate-bu¡ered saline without divalent cations, pH 7.4 (PBS(3)) three times and twice with tap water, and air-dried, and then the slide glass was dried and stored at 330³C until use. For staining of the cells, the slide glass was thawed in PBS (3) , and then the cell membrane was permeabilized by soaking the slide glass in methanol/acetone (1:1, v/v) at room temperature for 10 min. After extensive washing o¡ of the organic solvent with PBS(3), each samples was blocked with 20% FBS in bu¡er A, comprising 0.1% BSA and 0.1% sodium azide in PBS(3), at 37³C for 30 min. Then the cells were reacted with an anti-active caspase-3 antibody (Pharmingen, Cat. No. 67341A) at 1:100 dilution, an anti-total caspase-3 antibody (Pharmingen, Cat. No. 65906E) at 1:50 dilution or an a¤nity-puri¢ed polyclonal rabbit antibody raised against a synthetic peptide of Ser 15 -phosphate in human hsp27 (LLRSPS*WEPFRC-KLH) at 20 Wg/ml in bu¡er A at 37³C for 1 h, rinsed three times with PBS(3), and then reacted with FITC-labeled goat anti-rabbit IgG (Fab)P 2 (American Qualex, Cat. No. AI02FT) at 37³C for 30 min. The cells were rinsed with PBS(3) three times, reacted with 0.67 Wg/ml DAPI (Sigma) at 37³C for 10 min to stain nuclear DNA, and then rinsed with PBS(3) three times and ¢nally with tap water. The ¢nal sample was air-dried, covered with a layer of glycerol/ PBS(3) (4:1, v/v) containing 0.1% p-phenylenediamine (Sigma), and then covered with a cover glass. A Carl Zeiss Laser Scanning Microscope, model LSM 510, equipped with a £uorescent microscope (Carl Zeiss, model Axiovert 100M) and a c-Apochromat objective lens, was operated following the instruction manual with an excitation wavelength of 488 nm (Ar/Kr laser for FITC), and an emission wavelength of 505^550 nm for FITC, respectively. The results were analyzed with basic LSM510 software, and photographs were taken under £uorescent (FITC) or transmitted light (di¡erential interference contrast (DIC)) in random ¢elds.
Protein kinase assay and immunoblotting
JA-4 cells were seeded at 4.0U10 6 cells/8 ml/dish (Corning 25010), and then incubated at 37³C overnight. The medium was replaced with 5 ml of fresh medium, and then 100 WM SB202190 was added. After incubation for 15 min, 100 ng/ml LPS was added to the culture and the cells were incubated at 37³C for a further 15 min, after which MAP kinases were well activated and phosphorylated, as shown later. Then the cells were washed with PBS(3) twice, scraped o¡, pelleted by centrifugation at 4³C at 10 000 rpm brie£y, and then suspended in 100 Wl of the phosphorylation lysis bu¡er, composed of 0.1 mM EDTA, 10 mM NaF, 1 mM Na 3 VO 4 , 1% aprotinin and 0.1% Triton X-100 in 20 mM TrisĤ Cl (pH 7.5). After standing on ice for 30 min, the cells were centrifuged at 10 000 rpm for 1 min at 4³C, and then the resultant supernatant was used as the cell extracts. For immunoprecipitation, 100 or 200 Wg protein of cell extract was diluted to 2 or 4 Wg/ml with the phosphorylation lysis bu¡er for MAP-KAPK2, or p38, Erk1/Erk2 and JNK, respectively, followed by the addition of 2 Wg anti-MAPKAPK2 antibodies (Upstate Biotechnology, NY), 20 Wl immobilized phospho-p38 monoclonal antibodies, 5 Wl phospho-Erk1/Erk2 antibodies, or 5 Wl phospho-JNK antibodies (New England BioLabs, MA), respectively, and the immunoprecipitation was performed at 4³C for 16 h with continuous mixing. Then the immune complexes, other than that with immobilized phospho-p38 antibodies, were collected with protein G-or protein A-Sepharose beads by incubation at 4³C for an additional 1 h, and then the beads were washed with Ip-bu¡er A (20 mM Tris^HCl, pH 7.4, 0.1% Triton X-100, 0.15 M NaCl, 1% aprotinin, 0.02% NaN 3 ), Ip-bu¡er B (Ipbu¡er A+1 M NaCl), and Ip-bu¡er A, and ¢nally with the kinase reaction bu¡er (3ATP) mentioned below. The washed beads were suspended in 18 Wl of the kinase reaction bu¡er, comprising 10 mM MgCl 2 , 0.5 mM EGTA 3Na, 4 mM DTT, 2.5 WM ATP and 0.17 WM [Q-32 P]ATP (10 WCi, NEN) in 20 mM Tris3HCl, pH 7.5. The kinase reaction was started by the addition of 2 Wg hsp27 (StressGen Biotechnologies, Victoria, BC, Canada), 2 Wg GST-ATF2 (Santa Cruz Biotechnology, CA), 4 Wg GSTElk1 (New England BioLabs, MA), or 2 Wg GST-cJun (Santa Cruz Biotechnology, CA), followed by incubation at 28³C for 30 min, and terminated by the addition of 3USDS-sample bu¡er, ¢nally comprising of 1% SDS, 5% 2-mercaptoethanol, 20% glyc- Fig. 1 . Cell damage to JA-4 macrophages and detection of the insertion of nicks into DNA on TUNEL staining. In A, cells were treated ¢rst with DMSO (a^l), 25 WM TPCK (m,s), 20 WM herbimycin A (n,t), 100 U/ml polymyxin B (o,u), 1 mM Ac-DEVD-CHO (p,v), 250 WM Z-Asp-CH 2 -DCB (q,w), or 1 mM ZnCl 2 (r,x) for 15 min, then 100 WM SB202190 (c,i,e,k,m^r,s^x) or SB202474 (d,j,f,l) was added to the culture. After incubation for another 15 min, 100 ng/ml LPS was added (b,h,e,k,f,l,m^r,s^x) and the cells were incubated for a further 4 h. Then, photographs were taken under a phase-contrast microscope directly (a^f,m^r) or after TUNEL staining as described in the text (g^l,s^x). The dark staining in k represents TUNEL(+) cells, while light staining in other photographs (g^j,l, s^x) represents background staining of TUNEL(3) cells. Photographs were taken in random ¢elds at the same magni¢cation, and more than 150 cells were observed in each sample. In B, the cells were treated with the reagents except that the ¢nal incubation period after LPS addition was 90 min, and that the TUNEL staining was performed with an In Situ Cell Death Detection Kit, TMR red, as described in the text. Fluorescence of the TMR red incorporated into the apoptotic cells (a^f,m^r) was observed under a confocal microscope and the transmission light image was also examined as DIC images (g^l,s^x). More than 150 cells were observed in each sample and the photographs were taken under the same conditions from the representative ¢elds. Scale bar in a: 20 Wm.
erol, 1 mM EDTA and 0.05% bromophenol blue, and then boiling at 95³C for 5 min. Samples were loaded onto 5^20% gradient gels (PAGEL; Atto, Tokyo), and the gels were dried and visualized by autoradiography.
For Western blotting, 50, 75, and 100 Wg aliquots of cell extracts were treated with the SDS-sample bu¡er for p38, JNK, and Erk1/Erk2, respectively, and then boiled at 95³C for 5 min. Samples were loaded onto a 5^20% gradient gel, and electrotransferred to an Immobilon PVDF membrane (Millipore) at 30 V overnight and then at 100 V for 30 min. After blocking of the ¢lter with 30 mg/ml milk casein (Snow Brand, Sapporo), p38 and phosphorylated p38, Erk1/Erk2 and phosphorylated Erk1/Erk2, JNK and phosphorylated JNK were detected by a series of Phospho Plus MAPK Antibody Kits (New England BioLabs, MA), according to the manufacturer's protocols. hsp27 and phosphorylated hsp27 (phospho Ser 15 -hsp27) were detected with an antihsp27 antibody (StressGen) and a polyclonal antiphospho Ser 15 -hsp27 antibody, respectively, then with HRP-conjugated second antibodies (New England Biolabs), as described above.
Results
Cytotoxicity induced by LPS and a p38 MAPK inhibitor, SB202190
Remarkable changes in cell shape were observed when an LPS-sensitive JA-4 macrophage-like cell line was treated with LPS and a p38 MAPK inhibitor, SB202190, for 2 h or longer, and many cells were severely damaged at 4 h after the addition of LPS ( Fig. 1Ae) . However, an LPS-resistant mutant of JA-4 cells, the LPS1916 cell line, was not damaged (data not shown). Neither LPS nor SB202190 alone induced such cell damage (Fig. 1Ab,c) , and SB202474, an inactive analog of SB202190, did not induce cell damage in the presence of LPS (Fig. 1Af) . These results suggest that inhibition of p38 MAPK leads to induction of cytotoxicity toward LPS-treated macrophages.
Only the cells treated with both LPS and SB202190 showed TUNEL-positivity, indicating DNA nicks in these apoptotic cells (Fig. 1Ak) , although there were background stainings of the diaminobenzidine (DAB) in other samples. Phase-contrast micrographs showed that shrinkage of the cells, another feature of apoptosis, occurred during incubation with LPS and SB202190 (Fig. 1Ae) . In order to detect TUNEL(+) cells in the earlier time courses before morphological cell damage, the cells were treated under similar conditions, but only for 90 min and then stained with a more sensitive TUNEL kit using TMR red-conjugated nucleotide. As shown in Fig. 1B , only the cells treated with both LPS and SB202190 alone showed positive £uorescence ( Fig.  1Be ), but others did not, showing the similar results in Fig. 1A , but no cell damages in any case. It is also noteworthy that TUNEL(+) cells appeared before cell damage became evident, which will be shown later in the time course of LDH release (Fig. 3A) . Furthermore, LPS and SB202474 had little e¡ect, suggesting that the induction of apoptosis and cell damage were closely linked to both the action of LPS and the inhibition of p38 MAPK.
Addition of such inhibitors of LPS-induced macrophage activation as TPCK, herbimycin A or polymyxin B [21] to the cells treated with LPS and SB202190, abolished appearance of TUNEL(+) cells (Fig. 1As^u ,Bm^o, morphological cell damages ( Fig.  1Am^o ) and LDH release (data not shown). These results suggest that early LPS signals blocked by these inhibitors are involved in the pro-apoptotic pathway of the macrophages treated with LPS and SB202190.
Recently, caspase family members were reported to play important roles in the apoptosis of various cells [17^20] . Therefore, we examined the e¡ect of caspase inhibitors on the LPS-and SB202190-induced cytotoxicity. Z-Asp-CH 2 -DCB, a general caspase inhibitor, Ac-DEVD-CHO, a caspase-3-like protease inhibitor, and Zn 2 , an inhibitor of caspase-1,3,6-like activity in apoptotic JA-4 cell extracts [21] , all reduced the number of TUNEL(+) cells after treatment with LPS and SB202190 (Fig. 1Av^x,Bpr ). These results support the involvement of caspases, especially a caspase-3-like one, in the LPS-and SB202190-induced apoptosis, and that a caspase-3-like protease might cause the insertion of DNA nicks in the 3P-OH end as well as disruption of the membrane integrity in this apoptotic cell damage. Actually, active caspase-3 was only detected in the apoptotic cells treated with both LPS and SB202190, although total caspase-3, including most of the precursors and some of the activated form, was observed in all cells ( Fig. 2A) . However, LPS1916 cells showed neither active caspase-3 nor apoptotis, even after treatment with both LPS and SB202190 (Fig.  2B) . These results show that treatment with LPS and SB202190 activates caspase-3 in JA-4 cells, but not in LPS1916 cells, suggesting that the activation of caspase-3 and subsequent apoptosis is in£uenced by the LPS-responsiveness of the macrophages.
A time course study showed that there was a lag time before the release of LDH into the culture supernatant, a marker of cell damage due to a dysfunction of the cell membrane barrier [16] , in JA-4 cells after treatment with LPS and SB202190. Signi¢-cant release of LDH was ¢rst observed 2 h after addition of the reagents, which increased with time to about 25% after 4 h and to about 40% after 6 h (Fig. 3A) . However, no LDH release was observed from the macrophages treated with both LPS and SB202474, or with LPS alone (Fig. 3A) . These results show that the release of LDH may be used for quantitative estimation of the cell damage as morphologically seen in Fig. 1A , and we assayed the LDH release after 4 h incubation for quantitative estimation of the cytotoxicity hereafter.
The dose-dependence of the action of p38 MAPK inhibitors showed that SB202190 and SB203580, another speci¢c inhibitor of p38 MAPK, induced signi¢cant LDH release at and more than 50 and 75 WM, respectively (Fig. 3B) . Besides, SB202190 or SB203580 alone did not cause the LDH release even at 100 WM under the present experimental conditions (data not shown). On the other hand, an inactive analog of SB202190, SB202474, did not induce Fig. 2 . Activation of caspase-3 in macrophages treated with LPS and SB202190. In A, LPS-sensitive JA-4 cells were treated without any addition (a^d) or with 100 ng/ml LPS and 100 WM SB202190 (e^h) for 2 h, and then ¢xed directly with 3% formaldehyde. Total caspase-3 (a,e) or activated-caspase-3 (c,g) was detected with an anti-total caspase-3 antibody or an anti-active-caspase-3 antibody by confocal microscopy as described in the text. In B, LPS-resistant mutant, LPS1916, cells were treated similarly to JA-4 cells, but no active caspase-3 was detected.
cytotoxicity, even at 100 WM in the presence of LPS (Fig. 3B) . These results show that the induction of the cytotoxicity toward LPS-treated macrophages is dependent on p38 MAPK inhibition by SB202190 or SB203580, and that neither LPS alone nor the p38 MAPK inhibitor alone is able to induce cell damage, as shown by the morphological changes in Fig. 1 . Therefore, 100 WM SB202190 was used in the following experiments to induce the cytotoxicity with LPS, unless otherwise stated.
To identify the MAP kinases involved in the induction of the cytotoxicity, we examined the e¡ect of PD98059, a selective inhibitor of MEK1, on LPStreated macrophages. However, 100 WM PD98059 did not induce LDH release in the presence of LPS, as shown in Table 1 . Furthermore, an LPSresistant mutant of JA-4 cells, LPS1916 cells, did not show LDH release on treatment with LPS and SB202190 or SB203580 (Table 1) , as observed on mal-activation of caspase-3 in this mutant cell line JA-4 (LPS-sensitive) or LPS1916 (LPS-resistant) cells were treated with 100 WM SB202190, SB203580, SB202474, or PD98059 for 15 min at 37³C, followed by addition of 100 ng/ml LPS and further incubation for 4 h. The release of LDH was examined as described in the text. The results are the means þ S.E. for more than three independent experiments. n.d., not determined. , and then 100 ng/ml LPS was added, followed by incubation for the times indicated on the abscissa. Then, the culture supernatants were collected and the LDH release was examined as described in the text. The results are the means þ S.E. for three independent experiments. (B) Dose-dependence of p38 inhibitors as to induction of the cytotoxicity in LPS-treated macrophages. Cells were treated with various concentrations of SB202190 (closed circles), SB203580 (closed squares), or SB202474 (closed triangles) for 15 min, and incubated with 100 ng/ml LPS for a further 4 h, and then the LDH release was examined. The results are the means þ S.E. for three independent experiments.
6 treated with LPS and SB202190 (Fig. 2B) . These results suggest that the macrophage cell damage is selectively induced only in an LPS-sensitive cell line, JA-4, by the combination of LPS-treatment and the inhibition of p38 MAPK.
3.2. Analysis of the MAP kinase cascade in LPS-treated macrophages in the presence or absence of the p38 MAPK inhibitor
We next examined the e¡ect of SB202190 on the phosphorylation of p38, Erk1/Erk2, or JNK after LPS-treatment to examine the speci¢city of this reagent as to the phosphorylation of MAP kinases, which has been believed to be a necessary step for manifestation of the activities of these kinases [222 4]. As shown in Fig. 4Aa ,c, LPS alone induced a transient increase in the phosphorylation of p38 and Erk1/Erk2, with a peak at 15 min and 7.5^15 min after LPS addition, respectively. However, the phosphorylation of JNK was biphasic; the ¢rst peak appeared at 15 min and the second one at 90 min, as shown in Fig. 4Af . The expression of total p38, Erk1/ Erk2, or JNK protein did not change signi¢cantly with or without LPS in this time course (Fig.  4Ab,d,f) . On the other hand, SB202190 or SB202474 did not change the phosphorylation of p38 until 15 min after LPS addition (Fig. 4Ba,Ca) as compared with the vehicle, DMSO (Fig. 4Aa) . However, phosphorylation of p38 in the presence of SB202190 (Fig. 4Ba) and SB202474 (Fig. 4Ca) later than 15 min after addition of LPS remained almost constant at the maximal level up to 90 min, although the results at 90 min on treatment with LPS and SB202474 are not shown in Fig. 4Ca . Similar results were obtained for the phosphorylation of Erk1/Erk2 on treatment with LPS and SB202190 or SB202474 (Fig. 4Bc,Cc) , although the amount of the lower band of phospho-Erk1/Erk2 had decreased slightly at 30 or 60 min after treatment with C Fig. 4 . E¡ect of SB202190 or SB202474 on LPS-induced phosphorylation of p38, Erk1/Erk2, or JNK kinase. Cells were treated with 0.5% DMSO (A), 100 WM SB202190 (B), or 100 WM SB202474 (C) at 37³C for 15 min, without (lanes 1, 2, 4, 6, 8 and 10) or with 100 ng/ml LPS (lanes 3, 5, 7, 9 and 11), and then incubated for the times indicated at the top of each ¢gure. Finally, the cells were harvested and lysed, and aliquots of the extracts were subjected to SDS^PAGE/Western blotting as described in the text using a polyclonal anti-dual-phosphorylated p38 (a), anti-p38 (b), anti-dual-phosphorylated Erk1/Erk2 (c), anti-Erk1/Erk2 (d), anti-dual-phosphorylated JNK (e), or anti-JNK (e) antibody, respectively. SB202474 (Fig. 4Cc) , but not after that with SB202190 (Fig. 4Bc) . Moreover, neither SB202190 nor SB202474 a¡ected the change in LPS-induced phosphorylation of JNK in this time course (Fig.  4Be,Ce) . These results show that SB202190 and SB202474 give rise to no signi¢cant di¡erences in the phosphorylation of these MAP kinases in LPStreated macrophages, although both of them seem to retard the dephosphorylation of the phosphorylated p38 and Erk1/Erk2, but not that of JNK. These results also suggest that prolonged phosphorylation of p38 and/or Erk1/Erk2 is not enough to induce the cell damage to JA-4 cells that is speci¢cally caused by treatment with LPS and SB202190, but not by treatment with LPS and SB202474.
We next examined the e¡ect of SB202190 on the kinase activity of the phosphorylated p38, Erk1/ Erk2, or JNK. As shown in Fig. 5A [1] , SB202190 completely inhibited the phosphorylated p38 kinase activity at 10 WM in vitro, while SB202474 suppressed it slightly at 100 WM, showing the selective inhibition by SB202190 of the kinase activity of phosphorylated p38 in macrophage extracts. Neither SB202190 nor SB202474 a¡ected the activity of phospho-Erk1/Erk2 even at 100 WM in vitro (Fig.  5A [2] ). On the other hand, SB202190 inhibited the activity of phosphorylated JNK slightly but signi¢-cantly at 100 WM, while SB202474 failed to suppress it at all (Fig. 5A [3] ). The sensitivity of the phosphorylated p38 kinase activity toward SB202190 was more than 10-fold higher than that of the phosphor- 2) , 100 WM SB202190 (lanes 3 and 4), or 100 WM SB202474 (lanes 5 and 6) at 37³C for 15 min, then 100 ng/ml LPS was added to the cultures (lanes 2, 4 and 6), and then the cells were incubated at 37³C for another 15 min. Finally, the cells were lysed and the cell extracts were immunoprecipitated with an anti-MAPKAPK2 antibody. MAPKAPK2 immune complex kinase assays were performed with hsp27 as a substrate as described in the text. (C) E¡ect of SB202190 or SB202474 on LPS-induced phosphorylation of Ser-15 in hsp27. Cells were treated with 0.5% DMSO (lanes 1^3), 100 WM SB202190 (lanes 4 and 5) or 100 WM SB202474 (lanes 6 and 7) for 15 min at 37³C, and then incubated without (lanes 1, 2, 4 and 6) or with 100 ng/ml LPS (lanes 3, 5 and 7) for a further 0 (lane 1) or 60 min (lanes 2^7). Finally, the cells were lysed, and extracts of them were subjected to SDS^PAGE/Western blotting as described in the legend to Fig. 4 either with a polyclonal antiphospho Ser 15 -hsp27 antibody (upper lanes) or a monoclonal anti-hsp27 antibody (lower lanes). Representative results are shown from three independent experiments with similar results. ylated JNK, suggesting that SB202190 selectively inhibits p38 kinase activity among those of these MAP kinases at least in vitro.
Activation of p38 through phosphorylation at the 180Thr and 182Tyr sites has been reported to result in the phosphorylation of a downstream kinase, MAPKAPK2, followed by phosphorylation of hsp27 by the phosphorylated MAPKAPK2 [28^31]. Next, we examined the e¡ect of SB202190 on downstream kinases after LPS-induced phosphorylation of p38 in vivo. As shown in Fig. 5B , the addition of SB202190 to macrophages inhibited the p38 MAPK activity to the basal level in the presence or absence of LPS, resulting in no phosphorylation of hsp27 through impaired activation of MAPKAPK2, while that of SB202474 had little e¡ect. Besides, SB202190, but not SB202474, inhibited LPS-induced phosphorylations of hsp27 at 15 Ser in vivo, while it showed no e¡ects on the amount of total hsp27 in JA-4 cells incubated at 37³C for 60 min (Fig. 5C ). Similar results were obtained when the cells were incubated at 37³C for 15 or 90 min with or without LPS and/or SB202190 or SB202474 (data not shown). These results suggest that inhibition of the phosphorylated p38 MAPK activity by SB202190 in vivo might be linked to apoptosis of LPS-treated macrophages.
Existence of a threshold time for the addition of SB202190 to induce apoptosis of macrophages after treatment with LPS
To clarify the relationship between the inhibition of LPS-induced p38 MAPK activity and the induction of apoptosis, we examined the time course of addition of SB202190 to LPS-treated macrophages. There was no di¡erence in LDH release when SB202190 was added 15 min before or 15 min after LPS treatment, however, SB202190 scarcely induced apoptosis when it was added 30 min after LPS treatment (Fig. 6A ). This result shows that there is a threshold time for the induction of apoptosis by SB202190 in combination with LPS, suggesting that inhibition of p38 MAPK activity by 15 min after LPS-treatment is necessary for the induction of apoptosis. On the other hand, the increase in p38 MAPK activity in LPS-treated macrophages, as revealed by activation of MAPKAPK2 and subsequent phosphorylation of hsp27, peaked at 15^30 min (Fig.   6B ), which was near the threshold time for the addition of SB202190 to induce apoptosis of LPS-treated macrophages (Fig. 6A) . These results suggest that inhibition of p38 MAPK activity before it fully transduces the phosphorylated signals to downstream kinases might be necessary for the induction of apoptosis of LPS-treated macrophages.
Early signals involved in MAP kinase activation in LPS-and SB202190-treated macrophages
To examine upstream signals involved in MAP kinase activation in LPS-treated macrophages, polymyxin B, TPCK or herbimycin A was added prior Fig. 6 . The threshold time for the induction of apoptosis in LPS-treated macrophages by inhibition of p38 MAPK activity with SB202190. (A) Time course of SB202190 addition to LPStreated macrophages. SB202190 was added at 100 WM to the cells 15 min prior to, simultaneously with, or 15^90 min after LPS addition. Incubation was continued at 37³C for 4 h after the addition of 100 ng/ml LPS at 0 time, and then the release of LDH was examined as described in the text. The results are the means þ S.E. for three independent experiments. (B) Increase in p38 MAPK activity in vivo to activate MAPKAPK2 in LPS-treated macrophages. Cells were treated with (lanes 3, 5, 7, 9 and 11) or without (lanes 1, 2, 4, 6, 8 and 10) 100 ng/ml LPS at 37³C for the times given at the top, and then the cells were lysed and MAPKAPK2 kinase assays were performed with hsp27 as a substrate as described in the legend to Fig. 5B. to the addition of LPS. Polymyxin B and TPCK have been reported to inhibit LPS-induced signals at early stages [25, 26] , and herbimycin A is an inhibitor of tyrosine phosphorylation [27] , and all of these reagents inhibit LPS-induced TNF-K production by JA-4 cells, as we reported previously [21] . Polymyxin B or TPCK inhibited the phosphorylation of p38, JNK, and Erk1/Erk2 induced by LPS, while herbimycin A did not inhibit, but rather enhanced it (Fig.  7) . Similarly, the phosphorylation of p38, JNK, or Erk1/Erk2 induced by LPS in the presence of SB202190 was also inhibited by TPCK or polymyxin B, but not by herbimycin A, although the addition of SB202190 alone (lane 10 vs. lane 1) or together with LPS per se (lane 6 vs. lane 2) increased the phosphorylation of these MAP kinases from the corresponding control level without SB202190, respectively, at this time point (Fig. 7) . These results show that the phosphorylation of these three MAP kinases induced by LPS occurs downstream of the active sites of polymyxin B or TPCK in the presence or absence of SB202190. This may be one of the reasons why the apoptosis of macrophages induced by LPS and SB202190 was completely abolished by TPCK or polymyxin B (Fig. 1s,u) . These results suggest that the early signals in LPS-treated macrophages, which lead to the phosphorylation of p38, JNK, or Erk1/ Erk2, and are inhibited by polymyxin B and TPCK, are all necessary for the induction of apoptosis of the macrophages in the presence of SB202190.
Subcellular localization of phosphorylated
hsp27 (phospho Ser 15 -hsp27) in LPS-and SB202190-treated macrophages Next, we examined the subcellular localization of phosphorylated hsp27 (phospho Ser 15 -hsp27) in LPSand SB202190-treated macrophages, because hsp27 has been reported to be phosphorylated by activated MAPKAPK2 resulting from phosphorylation by the phosphorylated p38 [29, 30] . As shown in Fig. 8d , phosphorylated hsp27 increased on treatment with LPS, and was abundant in the periphery of the nucleus, particularly enriched in the Golgi area of the LPS-treated macrophages. This characteristic localization of phospho Ser 15 -hsp27 was not changed by addition of SB202474 (Fig. 8f) , although SB202474 itself seemed to elevate the expression of phosphorylated hsp27 in the Golgi area even in the absence of LPS (Fig. 8c) . However, SB202190 inhibited the recruitment of the phosphorylated hsp27 to the Golgi area in LPS-treated macrophages, but most of the phospho Ser 15 -hsp27 localized along the nuclear envelope (Fig. 8e) . These changes in the amount of phospho Ser 15 -hsp27 seemed to be correlated with those in the Western blot (Fig. 5C ), i.e. LPS increased expression of hsp27 phosphorylation signi¢-cantly and this was suppressed by addition of SB202190 selectively. These results suggest that SB202190 inhibited the rise in phosphorylation of hsp27 and enrichment of it in the Golgi area via activation of MAPKAPK2 by the phosphorylated p38 MAP kinase in LPS-treated macrophages, implying some correlation with induction of apoptosis.
Discussion
In the present study, a novel apoptosis and subsequent cell damage were observed in the macrophages 8) , or 100 U/ml polymyxin B (lanes 5 and 9) at 37³C for 15 min. Then, 0.25% DMSO (lanes 1^5) or 100 WM SB202190 (lanes 6^10) was added and the cells were incubated for an additional 15 min, followed by incubation with (lanes 2^9) or without (lanes 1 and 10) 100 ng/ml LPS for a further 15 min. Finally, the cells were chilled on ice, harvested and lysed, and extracts of them were subjected to SDS^PAGE/Western blotting as described in the legend to Fig. 4 with anti-dual-phosphorylated p38 (a), an antidual-phosphorylated Erk1/Erk2 (b), or anti-dual-phosphorylated JNK (c) antibody, respectively. treated with LPS and a p38 MAPK-speci¢c inhibitor, SB202190. The addition of SB202190 alone did not induce apoptosis or cell damage ( Fig. 1 and Table 1) , while it was enough to inhibit cellular phospho-p38 MAPK activity (Fig. 5B, lane 3) . The addition of LPS alone did not induce apoptosis or cell damage either ( Fig. 1 and Table 1 ), while it elevated the levels of phosphorylated p38, Erk1/Erk2 and JNK (Fig.  4A) . Moreover, LPS itself elevated phospho-p38 MAPK activity in vivo (Fig. 5B, lane 2, Fig. 5C,  lane 3) . Therefore, selective inhibition of phosphop38 MAPK by SB202190 (Fig. 5A) is not enough, or elevation of all these MAPK activities by LPS (Fig. 5A,B) is not su¤cient either, for the induction of apoptosis. However, the combination of the two, namely, the selective inhibition of the activity of phospho-p38 MAPK by SB202190 among the MAPK activities elevated by LPS-treatment, initiates the apoptotic cascade in the macrophages. Moreover, a time-course study of SB202190 addition to LPStreated macrophages showed that 15 min after LPS addition was the threshold time for induction of the maximal level of apoptosis (Fig. 6A) , and it was also the time when LPS-induced phosphorylation of p38 MAPK (Fig. 4A) was at its peak, as was the activation of MAPKAPK2, too (Fig. 6B) . These results show that inhibition of phospho-p38 MAPK activity by SB202190 is necessary before p38 MAPK transduces its phosphorylated signals fully to downstream targets after LPS-treatment. These results also imply that, in other words, macrophages escape from death signals when LPS transduces signals via p38 MAP kinase cascades to downstream e¡ector molecules, which cease triggering apoptotic pathways.
In various types of cells, MAP kinases have been shown to be involved in apoptosis. An increase in the activity of p38 or JNK has been reported in Fasinduced apoptosis of T-cells [12, 14] ; transfection of a constitutively active form of MKK6 or MKK3, a direct upstream kinase of p38, induced apoptosis . Cells were treated with 0.5% DMSO (a,d), 100 WM SB202190 (b,e), or 100 WM SB202474 (c,f) for 15 min, and then the cells were incubated without (a^c) or with 100 ng/ ml LPS (d^f) for an additional 60 min. Then, the cells were ¢xed directly with 3% formaldehyde. Phospho Ser 15 -hsp27 was detected with an anti-phospho Ser 15 -hsp27 antibody and an FITC-labeled second antibody, as described in the text. [12, 14] , or transfection of dominant-negative MEKK1, an upstream kinase of JNK, inhibited apoptosis [32] . However, the addition of SB202190 did not a¡ect Fas-induced apoptosis [12, 14] , suggesting that sustained phosphorylation of p38 MAPK by an activated upstream kinase, such as MKK6 or MKK3, is necessary to induce apoptosis in Fas-activated T-cells. However, our data showed that inhibition of p38 MAPK activity was required together with continuous phosphorylation of p38 MAPK to induce apoptosis, because SB202474 did not induce apoptosis, even though it induced sustained phosphorylation of p38 MAPK as SB202190 did in LPS-treated macrophages (Figs. 1, 3 and 4B) . In LPS-signaling pathways, such inhibitors as polymyxin B and TPCK [15, 21, 25, 26] had inhibited the phosphorylation of p38 by 15 min (Fig. 7) , and the subsequent apoptosis ( Fig. 1 ) and LDH release (data not shown) at 4 h in JA-4 cells treated with LPS and SB202190. A similar pattern of inhibition by these reagents was observed in the phosphorylation of the three MAP kinases of the macrophages treated with LPS, but not with SB202190 (Fig. 7, lanes 3 and  5) . These results show that the inhibitory site of polymyxin B or TPCK is prior to the phosphorylation of p38, and suggest that this apoptosis requires early LPS signals which are also necessary for LPS-induced TNF-K production [21] . On the other hand, herbimycin A, a general inhibitor of tyrosine kinases [27] and has been reported to inhibit the tyrosine phosphorylation of ras or raf-1 kinase, which is upstream of the Erk1/Erk2 cascade [10] , strongly inhibited LPS-induced TNF-K production by JA-4 cells [21] . However, 20 WM herbimycin A failed to suppress the phosphorylation of p38, JNK, or Erk1/ Erk2 by 15 min (Fig. 7, lane 4) , as well as the activation of caspase-3 by 120 min in LPS and SB202190-treated macrophages (data not shown). Instead, herbimycin A inhibited the LPS-and SB202190-induced apoptosis at 4 h, as judged by TUNEL-staining (Fig. 1At) and the LDH release (data not shown). These results suggest that herbimycin A inhibits the apoptotic pathway not at an early LPS signaling step before the activation of caspase-3, but rather in late apoptotic steps before the 3P-OH cleavage of DNA and the subsequent macrophage cell death. A study on the target of herbimycin A in LPS-and SB202190-treated macrophages is now in progress.
Although there is some evidence that shows apoptosis of the macrophages after treatment with LPS and SB202190 (Figs. 1 and 2) , it remains largely unknown how inhibition of p38 MAPK leads to activation of caspase-3, a key enzyme to trigger apoptosis of macrophages [15] .
As shown in Fig. 1 [12, 14, 32] . However, not only Ac-DEVD-CHO and Z-Asp-CH 2 -DCB, but also Zn 2 failed to suppress the LPS-and SB202190-induced p38 phosphorylation at the concentrations su¤cient to suppress apoptosis (data not shown), suggesting that the active sites of these caspase inhibitors do not reside at sites upstream of p38 phosphorylation, but instead at later stages following the elevation of p38 MAPK phosphorylation and inhibition of phospho-p38 MAPK activity by SB202190 in LPS-treated macrophages.
Under the apoptotic conditions, MAP kinases other than p38 and the kinases upstream of p38, such as MKK3 and MKK6, seemed to be elevated, or phosphatase activity towards phospho-p38 MAP kinase might have been suppressed in the macrophages after LPS-and SB202190-treatment. As a result of inhibition of p38 MAPK activity in LPS-treated macrophages by SB202190 but not by SB202474, downstream kinases such as MAPKAPK2 are not to be activated and thus might lose the ability to protect cells from death signals through apoptosis.
Among the downstream targets of p38, hsp27 has been well studied, it being implicated that the expression of hsp27 enhances cell survival and renders the cells resistant to apoptosis [38] via phosphorylation of hsp27 and the subsequent increase in the intracellular concentration of glutathione (GSH) [39] . We investigated the relationship between the intracellular GSH level and the induction of apoptosis. Overnight incubation of JA-4 cells with 1 mM buthionine sulfoximine reduced the level of GSH to about 10% of the untreated control level, however, it had no e¡ect on the cell damage to LPS-treated macrophages in the presence or absence of SB202190 or SB202474 (data not shown). Moreover, the cellular concentration of GSH did not change concomitantly with apoptotic changes; i.e. non-apoptotic conditions after treatment with 0.5% DMSO (10.7 þ 1.8 nmol/mg cell protein), 100 WM SB202190 (7.9 þ 0.3 nmol/mg), 100 WM SB202474 (14.7 þ 0.4 nmol/mg), LPS+DMSO (9.7 þ 0.8 nmol/mg), or LPS+SB202474 (12.3 þ 0.5 nmol/mg) vs. apoptotic conditions with LPS+SB202190 (10.5 þ 0.9 nmol/ mg) at 37³C for 90 min, respectively. These results suggest that the GSH level is not a critical factor in the induction of apoptosis, and is not tightly regulated by inhibition of p38 MAPK activity in LPSand SB202190-treated macrophages under the conditions in the present study. On the other hand, SB202190 selectively inhibited the rise in phosphorylation of Ser-15 of hsp27 in vivo (Fig. 5C ), suggesting that phosphorylation of hsp27 at this point by activated MAPKAPK2 after phosphorylation of p38 MAPK is not correlated with the change of cellular GSH levels at least.
We also showed the increased expression of phosphorylated hsp27 in JA-4 cells in response to LPS, which was greatly abolished by SB202190, but not by SB202474 (Figs. 5C and 8) . Besides, only SB202190 inhibited the recruitment of phospho Ser 15 -hsp27 to the Golgi area induced by LPS (Fig.  8) . Although not certain at present, it is suggestive that these morphological changes in the localization of phospho Ser 15 -hsp27 in LPS-and SB202190-treated macrophages have some relationship to the induction of apoptosis via the activation of caspase-3. In addition, the concentration of SB202190 to inhibit LPS-induced p38 activity completely to phosphorylate MAPKAPK2 was 5 WM. However, more than 50 WM SB202190 was necessary to induce apoptosis (Fig. 3B) . These results show that the inhibition of the phosphorylation of hsp27 at Ser 15 seems to be necessary, but not su¤cient, to induce apoptosis, implying the presence of other targets of SB202190 in LPS-treated macrophages.
In conclusion, it is suggested that LPS activates pro-apoptotic and anti-apoptotic pathways in the J774.1 macrophage-like cell line, and the anti-apoptotic pathway is through the p38 MAPK pathway. Furthermore, the inhibition of this apoptosis by TPCK and a tyrosine kinase inhibitor suggests that a serine protease(s) and tyrosine kinase are involved in the pro-apoptotic pathway induced by LPS. This study will provide a novel, useful information on the role of p38 MAPK activity in the regulation of apoptosis of LPS-treated macrophages.
